Hubly Surgical develops the Hubly Drill, a patented device aimed at enabling bedside cranial surgery and advancing bedside neurosurgery. The company received recent FDA clearance for the Hubly Drill. Hubly intends to use new funding to bring the Hubly Drill to market and to drive further surgical advancements. The firm was founded in 2019 by CEO Casey Qadir. Hubly positions its product to improve patient outcomes and quality of care across both standard and underserved settings. The company raised $3M in funding to support these plans. Hubly Surgical posted on LinkedIn thanking TechRise Chicago and expressing gratitude for the Chicago ecosystem. The post announces founder Casey Grage won $25,000 of non-dilutive capital at the LIVE Deep TechRise competition. That competition was hosted at the TechChicago BIPOC in Biotech event. The article does not provide details on Hubly Surgical’s core product, business model, revenue, users, or other operating metrics. The post names other Deep Tech pitches at the event, including Acorn Genetics, Ana Cornell, bTech, Vasowatch, CertAlert, and others. It also thanks judges Tunde Akinniranye, Nick Davis, ScD, and Dimitra Georganopoulou. No investors, past rounds, founding year, or specific financial terms beyond the $25K prize are mentioned in the article.

Total raised

$3M

Funding rounds

2

Latest round

Seed

Latest activity

Jul 2023